Fredrik Ivars
21 – 30 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Induction of NFκB responses by the S100A9 protein is TLR4-dependent.
(
- Contribution to journal › Article
-
Mark
S100A9 and tumor growth.
(
- Contribution to journal › Article
- 2011
-
Mark
S100A8/A9 in bleomycin-induced skin fibrosis
2011) 31st European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 70(Suppl. 2).(
- Contribution to journal › Published meeting abstract
-
Mark
Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: Block of initiation of proliferation of Gr-1(+) cells.
(
- Contribution to journal › Article
- 2010
-
Mark
Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.
(
- Contribution to journal › Article
-
Mark
Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757.
(
- Contribution to journal › Article
- 2009
-
Mark
Endothelial basement membrane laminin alpha 5 selectively inhibits T lymphocyte extravasation into the brain
(
- Contribution to journal › Article
-
Mark
T-cell tolerance induced by repeated antigen stimulation: Selective loss of Foxp3(-) conventional CD4 T cells and induction of CD4 T-cell anergy.
(
- Contribution to journal › Article
-
Mark
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.
(
- Contribution to journal › Article